Hematology/Oncology Master List of Peer Reviewed Studies
14 November 2021
Thrombosis with Thrombocytopenia following Moderna: https://www.acpjournals.org/doi/full/10.7326/L21-0244
TTP Following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34264514/
DVT and PE and positive HIT panel following mRNA Vaccine: https://pubmed.ncbi.nlm.nih.gov/34117206/
Superior ophthalmic Vein Thrombosis and Thrombocytopenia following AstraZeneca: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265377/
Autoimmune hemolytic anemia: https://pubmed.ncbi.nlm.nih.gov/34150386/
Autoimmine hemolytic anemia following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34258873/
ITP Exacerbation in 12% of chronic patients: https://pubmed.ncbi.nlm.nih.gov/34075578/
ITP Exacerbation in previous stable patient following Pfizer: https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofab343/6308965
ITP following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34155844/
ITP following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34382388/
ITP in 1st trimester of pregnancy 13 days following vaccination in the US: https://pubmed.ncbi.nlm.nih.gov/34420249/
Secondary ITP and resulting hemorrhage and hematoma after minor oral surgery after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34314875/
3 cases of ITP following Pfizer and Astra Zeneca: https://www.mjhid.org/index.php/mjhid/article/view/4669/4043
Treatment Guide to Thrombotic Thrombocytopenia Following Vaccination: https://www.hematology.org/covid-19/vaccine-induced-immune-thrombotic-thrombocytopenia
36 Cases of ITP following Pfizer and Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011062/
20 cases of Thrombocytopenia following Pfizer and Moderna: https://onlinelibrary.wiley.com/doi/10.1002/ajh.26132
26yoF with ITP following Moderna: http://pubs.sciepub.com/ajmcr/9/8/3/index.html
84yoM with ITP following Pfizer: https://link.springer.com/article/10.1007/s11739-021-02778-w
41yoF with ITP following Pfizer: https://casereports.bmj.com/content/14/5/e242220
69yoF with refractory ITP following Pfizer: https://journals.lww.com/americantherapeutics/Citation/2021/08000/Immune_Thrombocytopenic_Purpura_Associated_With.24.aspx
20yoF with ITP following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34381692/
3 cases reports of ITP following Pfizer and J&J: https://ehoonline.biomedcentral.com/articles/10.1186/s40164-021-00235-0
54yoF with ITP following Pfizer: https://www.cureus.com/articles/56899-newly-diagnosed-idiopathic-thrombocytopenia-post-covid-19-vaccine-administration
74yoM with ITP following Moderna: https://www.dovepress.com/severe-refractory-immune-thrombocytopenia-occurring-after-sars-cov-2-v-peer-reviewed-fulltext-article-JBM
26yoF with ITP following Moderna: http://pubs.sciepub.com/ajmcr/9/8/3/index.html
3 cases: recurrent AvWD and acquired hemophilia A after Moderna, PNH flare following Moderna, and ITP flare following Moderna: https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic
3 cases of ITP in elderly patients following vaccination: https://www.hindawi.com/journals/crihem/2016/7913092/
3 patients with venous thromboembolism following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34352418/
ITP and diffuse papular rash following Moderna: https://www.scienceopen.com/document_file/691feaa0-8e64-40c4-9553-40382bd5ac48/PubMedCentral/691feaa0-8e64-40c4-9553-40382bd5ac48.pdf
ITP and AIHA following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274740/
PE, TIA, and thrombocytopenia after J&J: https://pubmed.ncbi.nlm.nih.gov/34261635/
Acquired TTP following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34309715/
TTP in an adolescent following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34405400/
Thrombocytopenia in a teen with sickle cell disease following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34331506/
5 cases of prothrombotic immune thrombocytopenia after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34323939/
Review of 50 cases of thrombocytopenia following Astrazeneca, Pfizer, Moderna: https://pubmed.ncbi.nlm.nih.gov/34332437/
68yoF with extensive thrombosis after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34400433/
Thrombotic Thrombocytopenia after AstraZeneca: Autopsy findings: https://pubmed.ncbi.nlm.nih.gov/34355379/
Fatal ICH due to Thrombotic Thrombocytopenia following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34402235/
Five cases with a combination of cerebral venous thrombosis, intracerebral hemorrhage and thrombocytopenia following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34393988/
Confusion and abdominal pain due to VITT following vaccination: https://pubmed.ncbi.nlm.nih.gov/34346657/
Fatal thromboembolism in a patient with preexisting thrombocytopenia following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34344867/
Malignant CVA due to VITT following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34341358/
Haemophagocytosis and atypical lymphocytes on bone marrow biopsy following vaccination: https://pubmed.ncbi.nlm.nih.gov/34312842/
4 cases of axillary adenopathy following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34303188/
Axillary lymphadenopathy following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34156552/
Unilateral Lymphadenopathy: https://pubmed.ncbi.nlm.nih.gov/33713605/
Cervical lymphadenopathy following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204135/
13 cases of Cervical lymphadenopathy: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241354/
DOTATATE PET-avid axillary lymph node after injection of the Johnson & Johnson: https://pubmed.ncbi.nlm.nih.gov/34269723/
Avid left axillary nodes and intense diffuse splenic uptake and moderate diffuse bone marrow uptake on PET 1 week after vaccination: https://pubmed.ncbi.nlm.nih.gov/34269722/
Axillary adenopathy following AstraZeneca resulting in possible misinterpretation of PET scan in metastatic melanoma patient: https://pubmed.ncbi.nlm.nih.gov/34414110/
163 cases of axillary adenopathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34257025/
Ipsilateral axillary adenopathy following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34333959/
Incidence of axillary adenopathy on Breast Imaging following Vaccination: https://pubmed.ncbi.nlm.nih.gov/34292295/
Supraclavicular lymphadenopathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34414929/
50yoM with adenopathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34406229/
Review of 24 cases of lymphadenopathy and their ultrasound findings in the US: https://pubmed.ncbi.nlm.nih.gov/34356507/
Kikucki-Fujimoto disease following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34395192/
Mammographic and sonographic findings in the breast and axillary tail following vaccination: https://pubmed.ncbi.nlm.nih.gov/34340203/
Vaccine related unilateral axillary lymphadenopathy:pattern on screening breast MRI: https://pubmed.ncbi.nlm.nih.gov/34325221/
Evolution of lymphadenopathy at PET/MRI after vaccination: https://pubmed.ncbi.nlm.nih.gov/34310229/
DOTATOC-avid lymphadenopathies induced by mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34363083/
FDG uptake in axillary lymph nodes after vaccination: a pitfall case of highly suspicious lymph nodes metastases of malignant melanoma: https://pubmed.ncbi.nlm.nih.gov/34412144/
Abnormal PET following vaccination: https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.29262
Vaccination effect on tracer uptake with FDG-PET/CT: https://pubmed.ncbi.nlm.nih.gov/34297113/
False Positive FDG PET CT after vaccination in a woman treated for metastatic breats cancer: https://pubmed.ncbi.nlm.nih.gov/34308402/
Positive PET following vaccination: https://pubmed.ncbi.nlm.nih.gov/34301777/
3 cases of HLH following AstraZeneca: https://jcp.bmj.com/content/early/2021/07/22/jclinpath-2021-207760
40yoF with Henoch-Schonlein Purpura following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241653/